Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
19.23
+1.21 (6.69%)
At close: Aug 22, 2025, 4:00 PM
19.88
+0.65 (3.39%)
After-hours: Aug 22, 2025, 7:53 PM EDT

Viridian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
1,5701,5191,1451,17642964
Upgrade
Market Cap Growth
37.37%32.58%-2.58%173.76%568.00%321.43%
Upgrade
Enterprise Value
1,03097798989237944
Upgrade
Last Close Price
19.2319.1721.7829.2119.7716.45
Upgrade
PS Ratio
5147.415028.173647.53663.46144.9461.23
Upgrade
PB Ratio
4.812.262.592.982.290.54
Upgrade
P/TBV Ratio
4.813.154.864.657.97-
Upgrade
EV/Sales Ratio
3376.013236.513150.76503.65127.7941.48
Upgrade
Debt / Equity Ratio
0.050.030.050.010.000.00
Upgrade
Asset Turnover
0.0000.000.010.020.01
Upgrade
Quick Ratio
10.7114.9917.9312.7314.4811.96
Upgrade
Current Ratio
11.0115.4318.2712.9314.6812.14
Upgrade
Return on Equity (ROE)
-65.88%-48.48%-56.80%-44.57%-51.61%-163.07%
Upgrade
Return on Assets (ROA)
-39.77%-30.32%-34.37%-26.28%-29.75%-31.36%
Upgrade
Return on Capital (ROIC)
-42.60%-32.26%-36.80%-28.52%-32.28%-35.04%
Upgrade
Earnings Yield
-17.56%-17.78%-20.76%-11.05%-18.49%-172.21%
Upgrade
FCF Yield
-19.72%-15.33%-16.16%-8.05%-12.79%-46.39%
Upgrade
Buyback Yield / Dilution
-41.68%-51.68%-39.48%-169.22%-235.07%-70.27%
Upgrade
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q